BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26577115)

  • 1. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
    Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
    Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
    Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
    Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
    World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
    Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
    D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
    Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury.
    Mousessian AS; Nunes da Silva CP; Oba-Shinjo SM; Kolias AG; Paiva WS; Nagahashi Marie SK
    World Neurosurg; 2021 Mar; 147():e16-e24. PubMed ID: 33189916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
    Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
    J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
    D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
    Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
    Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
    Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
    Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
    Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.